MTC ANNOUNCES FORMATION OF HUBEI CELLULAR JOINT VENTURE COMPANY

PR Newswire | March 15, 1993 | Copyright 
 
    RICHMOND, B.C., March 15 /PRNewswire/ -- MTC Electronics Technologies Co. Ltd (NASDAQ: MTCEF) announced today that on Feb. 18 it signed a joint venture contract with Hubei San Gao Telecommunication Technology Development Corporation (Hubei San Gao) to form an equity joint venture company (Hubei PT MTC Communication Development Corporation Ltd.) that will build, own, and operate cellular telephone systems in Hubei Province of the People's Republic of China.  The joint venture contract has been approved by all levels of government including the Hubei Province Ministry of Foreign ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Osiris Teams Up With Consolidated Skateboards for the Drunk.
PR Newswire ; ...based skate/surf lifestyle brand, Osiris (http://www.osirisshoes.com...Wilson, Executive Vice President for Osiris, adds, "If they can make skate shoes...Can't we all have a little fun?" Osiris will be the first in a series of core...
Osiris Therapeutics Receives $8 Million Financing for Stem Cell Research and Production Expansion.
PR Newswire ; ...BALTIMORE, Md., Oct. 1 /PRNewswire/ -- Osiris Therapeutics, Inc. today announced that...trust, in which Alexandria purchased Osiris' research laboratories and pilot GMP...owners. As part of the transaction, Osiris received $8 million in guaranteed financing...
Osiris Completes Enrollment in Second Prochymal Phase III Trial for Graft vs. Host Disease.
Newspaper article from: Blood Weekly ; Osiris Therapeutics, Inc. (NASDAQ:OSIR) announced...the United States, Canada and Australia. Osiris has now completed enrollment in two pivotal...studies in the second half of 2009 (see also Osiris Therapeutics, Inc.). Additionally...
Osiris Therapeutics Reports Third Quarter 2008 Financial Results.(Financial report)
Newspaper article from: Clinical Trials Week ; Osiris Therapeutics, Inc. (NASDAQ:OSIR...for the third quarter of 2008 (see also Osiris Therapeutics, Inc.). Highlights and...President and Chief Executive Officer of Osiris. "As the commercial launch of Prochymal...
Major Shareholders of Osiris Therapeutics Elect to Extend Lock-up Agreement.
Business Wire ; Osiris Therapeutics to Present at the 2007 UBS...Sciences Conference COLUMBIA, Md. -- Osiris Therapeutics, Inc. (NASDAQ:OSIR...Chairman of the Board of Directors of Osiris, and certain entities with which he is...
Bureau van Dijk Premieres OSIRIS.(Brief Article)(Product Announcement)
Magazine article from: Information Today ; ...the first glimpse of its new product, OSIRIS, billed as a fully integrated public...analytical information solution. The OSIRIS database covers over 90 countries and...academic community. The information in OSIRIS is pulled from several sources and then...
Osiris Therapeutics Reports First Quarter 2007 Financial Results.(Financial report)
Business Wire ; BALTIMORE -- Osiris Therapeutics, Inc. (NASDAQ:OSIR...facility expansion for Osteocel([R]) "Osiris continues to execute its mission to develop...Mills, Ph.D., President and CEO of Osiris. "During 2007, we have the opportunity...
Osiris Discontinues Enrollment in Crohn's Study Due to Concerns with Trial Design.
Business Wire ; ...factor in decision COLUMBIA, Md. -- Osiris Therapeutics, Inc. (NASDAQ: OSIR...Mills, Ph.D. President and CEO of Osiris Therapeutics said, "We had a situation...We fully agree with the decision by Osiris to end enrollment in this trial due to...
Osiris Therapeutics Completes License and Research Agreement with Northwestern University for a Novel Cartilage-Forming Molecule
PR Newswire ; ...BALTIMORE, Nov. 13 /PRNewswire/ -- Osiris Therapeutics, Inc. has entered into...formation of cartilage. The agreement grants Osiris an exclusive worldwide license to patentable...diagnostic products that are commercialized by Osiris. Dr. Arthur Veis, Professor of Biochemistry...
Osiris Stem Cell Funding Totals $70 Million for 2005; Additional $19 Million in Private Equity Concludes a Successful Year of Stem Cell Development.
Business Wire ; BALTIMORE -- Osiris Therapeutics, Inc. announced that it has closed...financing round is the capstone to a successful year for Osiris," said C. Randal Mills, PhD, President and CEO of Osiris. "Our mission is to bring this remarkable stem...

Find more facts and information related to the article "MTC ANNOUNCES FORMATION OF HUBEI CELLULAR JOINT ..."